Hvivo (HVO)

Sector:

Health Care

Index:

FTSE AIM All-Share

27.25p
   
  • Change Today:
    -0.25p
  • 52 Week High: 30.50
  • 52 Week Low: 14.25
  • Currency: UK Pounds
  • Shares Issued: 680.37m
  • Volume: 601,061
  • Market Cap: £185.40m

Venn Life Sciences signs EUR1m contract

By Edward Swift

Date: Friday 23 Oct 2015

LONDON (ShareCast) - (ShareCast News) - Venn Life Sciences has signed a €1m contract with a leading French biotech company.
The AIM listed clinical research organisation announced the deal on Friday.

The two-phase project is centred on acute T-cell leukaemia, and will cover multiple regions including France, the UK and the US.

It will run for 33 months and follows on from a previous successful trial with the same company.

Chief executive Tony Richardson said the project "illustrates the high standard of execution for Venn's projects and how this can be used to generate repeat customer business".

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Hvivo Market Data

Currency UK Pounds
Share Price 27.25p
Change Today -0.25p
% Change -0.91 %
52 Week High 30.50
52 Week Low 14.25
Volume 601,061
Shares Issued 680.37m
Market Cap £185.40m

Hvivo Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
95.51% below the market average95.51% below the market average95.51% below the market average95.51% below the market average95.51% below the market average
81.25% below the sector average81.25% below the sector average81.25% below the sector average81.25% below the sector average81.25% below the sector average
Price Trend
96.18% above the market average96.18% above the market average96.18% above the market average96.18% above the market average96.18% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Income
94.72% below the market average94.72% below the market average94.72% below the market average94.72% below the market average94.72% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Growth
41.80% above the market average41.80% above the market average41.80% above the market average41.80% above the market average41.80% above the market average
77.78% above the sector average77.78% above the sector average77.78% above the sector average77.78% above the sector average77.78% above the sector average

What The Brokers Say

Strong Buy 3
Buy 3
Neutral 0
Sell 0
Strong Sell 0
Total 6
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Hvivo Dividends

  Latest Previous
  Final Special
Ex-Div 18-Apr-24 04-May-23
Paid 20-May-24 09-Jun-23
Amount 0.20p 0.45p

Trades for 16-May-2024

Time Volume / Share Price
16:29 10,000 @ 27.24p
16:29 2,000 @ 27.24p
16:17 366 @ 27.28p
16:09 6,250 @ 27.28p
16:05 56,100 @ 27.00p

Hvivo Key Personnel

CEO Yamin Mo' Khan

Top of Page